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OBJECTIVES We sought to determine which of the two main potential mechanisms underlying Throm-
bolysis In Myocardial Infarction flow grade 2 (TIMI-2 flow) operate in an individual patient
who has had an acute myocardial infarction (AMI).
BACKGROUND Systolic flow reversal (SFR) is a specific finding of capillary damage, the no-reflow
phenomenon. The coronary blood flow velocity (CBFV) pattern of thromboemboli, however,
remains unknown.
METHODS Data on 105 patients with AMI (57 with anterior and 48 with nonanterior cases) who
underwent a coronary intervention were analyzed. The CBFV was recorded by a Doppler
guide wire, and tissue perfusion was assessed with myocardial contrast echocardiography
(MCE).
RESULTS Study patients were classified into three groups according to TIMI grade and the presence or
absence of SFR: 1) TIMI-3 flow (n 80); 2) TIMI-2 flow with SFR (SFR[], n 14); and
3) TIMI-2 flow without SFR (SFR[-], n  11). Diastolic CBFV was the lowest in SFR(-)
(TIMI-3 vs. SFR[] vs. SFR[-]: 34 vs. 31 vs. 9 cm/s), and the systolic to diastolic CBFV
ratio was also the highest in SFR(-) (0.43 vs. 0.18 vs. 0.66). The no-reflow phenomenon
documented by MCE was found in all patients in the SFR() group, but in only one patient
(10%) in the SFR(-) group. Intracoronary thrombus was more frequently found in SFR(-)
than in SFR() (91% vs. 14%, p  0.05).
CONCLUSIONS At least two different CBFV patterns are noted in patients with reperfused AMI who have
TIMI-2 flow. Capillary damage is mostly responsible for SFR(), and SFR(-) is seen in
thromboemboli possibly due to increased coronary arterial resistance. (J Am Coll Cardiol
2002;40:1755–60) © 2002 by the American College of Cardiology Foundation
The patency of the infarct-related artery does not necessarily
guarantee the success of perfusion at the microvascular level
in patients with an acute myocardial infarction (AMI) (1).
The success of reperfusion therapy is usually evaluated
clinically by the Thrombolysis In Myocardial Infarction
(TIMI) flow grade, and a higher grade has been associated
with the better clinical and functional outcomes (2,3).
Although percutaneous coronary intervention (PCI) can
reduce the residual stenosis or prevent dissection as a cause
of TIMI flow grade 2 (TIMI-2 flow), TIMI-2 flow after
PCI can still be observed. Our previous study using myo-
cardial contrast echocardiography (MCE) demonstrated
that the no-reflow phenomenon, which implies a lack of
tissue perfusion due to capillary damage, is a cause of
TIMI-2 flow in patients with an anterior AMI (4). This
flow pattern has typical coronary blood flow velocity
(CBFV) characteristics, such as systolic flow reversal (SFR)
followed by forward diastolic flow with a rapid deceleration
slope (5–7). However, it remains unknown whether this
pattern is consistently observed in all patients with TIMI-2
flow.
Percutaneous coronary intervention may cause microem-
bolization of small arteries or arterioles, and this impairs
coronary blood flow and regional contractile function in the
absence of an atherosclerotic obstruction of an epicardial
coronary artery (8–13). In this instance, coronary arterial
resistance increases, and the CBFV pattern should be
different from that of capillary damage. In this study, we
hypothesized that an increase in coronary arterial resistance
should be associated with slow forward flow, with relative
augmentation of systolic flow, which is typically seen in
epicardial coronary stenosis.
METHODS
Study population. A total of 117 consecutive patients with
AMI who met the following criteria were prospectively
enrolled: 1) chest pain lasting 30 min and presenting
within 24 h after symptom onset; 2) ST-segment elevation
2 mm in at least two contiguous electrocardiographic
leads; 3) more than a threefold increase in serum creatine
kinase; 4) TIMI flow grade 0 or 1 of the infarct-related
artery on the baseline angiogram; and 5) successful coronary
recanalization (residual diameter stenosis 25%) after PCI.
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Twelve patients were excluded because of severe congestive
heart failure (n  5), an incomplete Doppler study (n  4),
recurrent infarction during follow-up (n  2), and previous
coronary artery bypass graft surgery (n  1). Thus, data
from 105 patients were analyzed. The study protocol was
approved by the ethics committee of our hospital, and
written, informed consent was obtained from all patients
before cardiac catheterization by an investigator.
Protocols. Aspirin (243 mg) was administrated to all pa-
tients before PCI. After administration of heparin (100
U/kg), coronary angiography and left ventriculography were
performed. Percutaneous coronary intervention was per-
formed using a Doppler guidewire. If TIMI-2 flow was
persistent after balloon angioplasty, we performed stenting
or intravascular ultrasonography to make sure that there was
no dissection or residual stenosis as a cause of TIMI-2 flow.
We graded TIMI flow by assessing the final coronary
angiogram after intracoronary administration of nitroglyc-
erin (0.3 mg).
The tip of the Doppler guidewire was positioned distal to
either the second diagonal branch of the left anterior
descending coronary artery or the obtuse marginal branch of
the left circumflex artery or in the atrioventricular branch of
the right coronary artery (7,14). After optimization of the
Doppler signal, CBFV was continuously recorded. Myocar-
dial contrast echocardiography was then performed using
intracoronary injection of microbubbles, as previously de-
scribed (1,15,16). Coronary angiography and left ventricu-
lography were repeated one month after PCI.
Analysis of the CBFV pattern. The CBFV spectrum,
recorded at a mean of 10 min after the final balloon
inflation, was analyzed (5). The following parameters were
calculated from the CBFV waveform: the time average of
peak CBFV (average peak velocity [APV], cm/s), systolic
and diastolic peak velocities, and deceleration time of the
diastolic velocity (ms). We also calculated the time-velocity
integral of CBFV and the effective coronary flow volume
(ml/min). The latter was determined as a product of the
time-velocity integral, heart rate, and cross-sectional area of
the coronary artery, with 0.5 used as a constant to correct for
the parabolic nature of the blood flow velocity profile within
the vessel. The cross-sectional area was calculated at 5 mm
distal to the tip of the Doppler guide wire, with the use of
a validated edge-detection program (Cardiovascular Mea-
surement System, Medis Medical Imaging System, Leiden,
the Netherlands). If SFR was present, the time-velocity
integral of reversed flow was subtracted from the forward
CBFV integral. These parameters were calculated by aver-
aging five continuous cardiac cycles.
Evaluation of angiographic data. The presence of intra-
coronary thrombus (ICT) was demonstrated on the coro-
nary angiograms before PCI. Previously defined criteria,
including filling defects, contrast staining, haziness, and
overhanging shoulders at the culprit lesion (17–19) were
employed. The grade of TIMI flow was evaluated after the
final PCI procedure, and the corrected TIMI frame count
was assessed (20,21). Left ventricular volume and ejection
fraction were measured from the biplane left ventriculo-
grams using the area-length method, and these two vari-
ables were corrected for body surface area. Regional wall
motion (standard deviation/chord) within the infarct zone
was calculated using the centerline method. The diameter
of the reference vessel and the minimal lumen diameter of
the culprit lesion were determined using quantitative an-
giography (Cardiovascular Measurement System, Medis
Medical Imaging System), and residual percent diameter
stenosis was calculated. Collateral channels were graded
using Rentrop’s classification (22). All measurements were
performed by an independent observer in a blinded manner.
Assessment of myocardial perfusion. An experienced
echocardiographer analyzed the MCE images indepen-
dently to determine the presence or absence of the no-
reflow phenomenon (1,15,16), which was determined to be
present when the endocardial length of the contrast defect
exceeded a quarter of that of the risk area.
Statistical methods. Continuously distributed variables
were expressed as the mean value  SD. One-way analysis
of variance and the Fisher post-hoc test were used to
compare continuous variables, and the chi-square test was
used to compare categorical variables. Multiple logistic
regression analysis was performed to identify independent
factors that were related to TIMI-2 flow without SFR. A p
value of 0.05 was considered statistically significant (two-
sided).
RESULTS
Patterns of CBFV with TIMI-2 flow. Of 105 patients, 24
(23%) had TIMI-2 flow after PCI. Figure 1 shows the two
typical predominant CBFV patterns in these patients. One
pattern shows SFR followed by rapid diastolic flow with a
steep deceleration slope, and the other pattern is character-
ized by slow anterograde systolic and diastolic flow velocity
waveforms. Thus, we classified the study patients into three
subgroups based on TIMI flow grade and the presence or
absence of SFR: 1) TIMI flow grade 3 (TIMI-3, n  80);
2) TIMI-2 flow with SFR (SFR[], n  14); and 3)
TIMI-2 flow without SFR (SFR[-], n  11).
Thirteen (93%) of 14 patients with SFR() had an
Abbreviations and Acronyms
AMI  acute myocardial infarction
APV  average peak velocity
CBFV  coronary blood flow velocity
ICT  intracoronary thrombus
MCE  myocardial contrast echocardiography
PCI  percutaneous coronary intervention
SFR  systolic flow reversal
TIMI  Thrombolysis In Myocardial Infarction
TIMI-2/3 flow  Thrombolysis In Myocardial Infarction
flow grade 2/3
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anterior myocardial infarction. In contrast, 8 (72%) of 11
patients with SFR(-) had an inferior myocardial infarction
(Table 1). There was no difference in the other baseline
characteristics among the three subgroups. All patients
showed a patent infarct-related artery at 28 days, with a
coronary diameter stenosis that was similar to that after
PCI. Stent deployment was more frequent in the SFR(-)
group, but the difference did not reach statistical signifi-
cance. The corrected TIMI frame count was the lowest in
the TIMI-3 group at day 1, but it was comparable at day 28
among the three subgroups. Heart rate and pulmonary
capillary wedge pressure were the highest in the SFR()
group.
Variables of CBFV. The APV was the highest in the
TIMI-3 group and was comparable between the SFR()
and SFR(-) groups (Fig. 2). Systolic APV was lower in the
SFR() group, whereas diastolic APV was lower in the
SFR(-) group (Table 2). The systolic to diastolic APV ratio
was the highest in the SFR(-) group, followed by the
Figure 1. Coronary blood flow velocity patterns in patients with reperfused
acute myocardial infarction with Thrombolysis In Myocardial Infarction
flow grade 2 (TIMI-2 flow). These two patients showed TIMI-2 flow after
a successful coronary intervention. (Left) Systolic flow reversal (SFR) is
observed in systolic followed by rapid diastolic flow, with a steep deceler-
ation slope. (Right) SRF is not observed. Very slow anterograde flow was
found throughout one cardiac cycle. Diastolic flow deceleration was gentle.
Table 1. Patient Characteristics and Baseline Data
TIMI-3 Group
(n  80)
TIMI-2 Groups
SFR()
(n  14)
SFR(-)
(n  11)
Age (yrs) 61  12 63  8 62  16
Male gender 70 (87%) 13 (93%) 10 (91%)
Coronary risk factors
Smoking 50 (63%) 7 (50%) 6 (65%)
Hypercholesterolemia 32 (40%) 5 (36%) 5 (45%)
Diabetes mellitus 20 (25%) 5 (36%) 4 (36%)
Hypertension 52 (65%) 6 (43%) 6 (55%)
Infarct-related artery
LAD 42 (52%) 13 (93%)* 2 (18%)
LCx 9 (11%) 0 0
RCA 29 (36%) 1 (7%) 9 (82%)*
Pre-MI angina 35 (44%) 7 (50%) 4 (36%)
Onset to reperfusion time (h) 9.3  8.3 8.1  5.9 9.9  7.2
Good collateral channel flow† 26 (32%) 6 (42%) 3 (27%)
Reference diameter (mm) 3.4  0.8 3.2  0.6 3.9  0.8*
Diameter stenosis after
PCI (%)
13.7  12.2 16.8  13.9 8.5  9.2
Stent implantation 42 (52%) 6 (43%) 8 (73%)
Diameter stenosis at 28 days 19.9  16.4 17.6  8.6 14.8  7.9
CTFC at day 1 20  11* 41  16 60  31*
CTFC at day 28 28  12 33  9 36  9
Mean aortic pressure
(mm Hg)
95  16 90  19 94  16
Diastolic aortic pressure
(mm Hg)
75.2  12.8 75.8  16.1 75.5  15.9
Heart rate (beats/min) 79  12 89  15* 73  19
PCWP (mm Hg) 11  6 17  6* 11  4
Right arterial pressure
(mm Hg)
5.1  3.4 5.2  2.6 7.2  2.9
*p  0.05 vs. other groups. †Good collateral flow implies Rentrop classes 2 and 3.
Data are expressed as the mean value  SD or number (%) of patients.
CTFC  corrected TIMI frame count; LAD  left anterior descending coronary
artery; LCx  left circumflex coronary artery; MI  myocardial infarction; PCI 
percutaneous coronary intervention; PCWP  pulmonary capillary wedge pressure;
RCA  right coronary artery; SFR  systolic flow reversal; TIMI-3 and TIMI-2 
Thrombolysis In Myocardial Infarction flow grade 3 and 2, respectively.
Figure 2. Distribution of the average peak velocity (APV) among the three
subgroups: Thrombolysis In Myocardial Infarction flow grade 2 (TIMI-2
flow) and TIMI-2 flow with systolic flow reversal (SFR)() and without
SFR(-). The APV was highest in the TIMI-3 group and comparable
between the SFR() and SFR(-) groups (25.5 11.8 vs. 13.8 7.1 vs. 7.1
 3.6 cm/s [mean  SD]).
Table 2. Coronary Blood Flow Velocity Variables
TIMI-3 Group
(n  80)
TIMI-2 Groups
SFR()
(n  14)
SFR(-)
(n  11)
APV (cm/s) 25.5  11.8* 13.8  7.1 7.1  3.6
Time velocity integral
(cm)
19.2  9.3* 9.5  5.1 6.5  3.8
Effective CFV
(ml/min)
70.3  50.9* 36.3  29.6 32.5  19.6
Systolic reverse flow 10 (13%) 14 (100%)* 0
SAPV (cm/s) 13.4  9.1 6.9  12.7* 6.1  2.9*
DAPV (cm/s) 33.5  17.4 30.8  14.9 9.2  3.9*
SAPV/DAPV 0.43  0.21 0.18  0.26* 0.66  0.12*
DDT (ms) 750  400 220  100* 1,040  500*
*p  0.05 vs. other groups. Data are expressed as the mean value  SD or number
(%) of patients.
APV  average peak velocity; CFV  coronary flow volume; DAPV  diastolic
APV; DDT diastolic deceleration time; SAPV systolic APV; other abbreviations
as in Table 1.
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TIMI-3 group, and then the SFR() group. The diastolic
deceleration time was the shortest in the SFR() group,
and it was the longest in the SFR(-) group. Systolic flow
reversal was observed in 10 patients with TIMI-3 flow, but
their APV was higher than that in the SFR() group (25.7
 8.5 cm/min vs. 13.8  7.1 cm/min, p  0.05). A similar
comparison of CBFV and hemodynamic variables among
the patients with an inferior AMI is illustrated in Table 3.
The APV was also lower and the systolic to diastolic APV
ratio was higher in the SFR(-) group than in the TIMI-3
group. The time-velocity integral of CBFV and effective
coronary flow volume were higher in the TIMI-3 group
than in the SFR() and SFR(-) groups, and these variables
were comparable between SFR() and SFR(-). Aortic
pressure and right arterial pressure were comparable among
the three groups.
Functional, morphologic, and clinical outcomes. Table 4
compares the functional and morphologic outcomes among
the three groups. Peak creatine kinase was the highest in the
SFR() group, followed by the SFR(-) group and the
TIMI-3 group. Regional wall motion and left ventricular
ejection fraction at 28 days were the lowest in the SFR()
group. The magnitude of changes in regional wall motion
between days 1 and 28 was the highest in the TIMI-3 group
and was comparable for the SFR() and SFR(-) groups.
The left ventricular end-diastolic or end-systolic volume
index at 28 days was also the highest in the SFR() group.
Congestive heart failure and malignant arrhythmia were
most frequently observed in the SFR() group, implying
that in-hospital clinical outcomes seem to be the worst in
SFR().
Factors related to TIMI-2 flow without SFR. All 14
patients (100%) with SFR() showed the no-reflow phe-
nomenon, and this frequency was significantly (p  0.001)
higher than that in those with TIMI-3 flow (6 [5%] of 80
patients) and in those with SFR(-) (1 [9%] of 11 patients).
Before PCI, ICT was most frequently (p  0.01 vs. other
groups) observed in the SFR(-) group (10 [91%] of 11
patients), compared with the TIMI-3 group (27 [34%] of
80 patients) and SFR(-) group (2 [14%] of 14 patients).
Multiple logistic regression analysis using age, gender, heart
rate, pulmonary capillary wedge pressure, mean aortic pres-
sure, collateral grade, infarct-related artery, history of pre-
AMI angina, ICT, reference vessel diameter, and interval
from onset to reperfusion showed that ICT was the only
independent predictor of SFR(-) (p  0.05).
DISCUSSION
The new finding of this study is that there are at least two
different CBFV patterns in patients with TIMI-2 flow:
SFR() associated with the no-reflow phenomenon and
SFR(-) associated with a thrombus burden. As expected,
both patterns were associated with worse functional and
clinical outcomes, as compared with TIMI-3 flow, and
Table 3. Coronary Flow Velocity and Hemodynamic Variables
in Patients With Inferior Acute Myocardial Infarction
TIMI-3 Group
(n  29)
TIMI-2 Groups
SFR()
(n  1)
SFR(-)
(n  9)
APV (cm/s) 23.1  9.4* 5.4 6.8  3.4
SAPV (cm/s) 12.5  5.4† 3.1 5.3  2.3
DAPV (cm/s) 28.0  13.9* 13.6 8.7  4.0
SAPV/DAPV ratio 0.47  0.15† 0.23 0.63  0.10†
DDT (ms) 830  410 252 1,230  500†
Diastolic aortic pressure
(mm Hg)
71.5  13.4 60 76.5  21.9
Right arterial pressure
(mm Hg)
6.4  3.3 5 7.5  2.6
*p  0.05 vs. SFR(-). †p  0.05 vs. other groups. Data are expressed as the mean
value  SD or number (%) of patients.
Abbreviations as in Tables 1 and 2.
Table 4. Temporal Changes in Left Ventricular Function and Volume and Clinical Outcomes
TIMI-3 Group
(n  80)
TIMI-2 Groups
SFR()
(n  14)
SFR(-)
(n  11)
Peak CPK (IU/l) 2,530  2,180 6,560  2,230* 3,040  1,980
LVEF at day 1 (%) 52.8  11.1 33.9  11.8* 61.0  10.6
LVEF at day 28 (%) 57.7  11.2 33.7  13.9* 56.8  10.9
RWM at day 1 (SD/chord) 2.96  0.65 3.46  0.29* 2.77  0.86
RWM at day 28 (SD/chord) 2.00  0.97 3.35  0.38* 2.61  0.71
RWM (SD/chord) 0.96  0.84* 0.10  0.29 0.16  0.77
LVEDVI at day 1 (ml/m2) 81.6  20.3 88.8  15.7 83.3  23.5
LVEDVI at day 28 (ml/m2) 80.7  19.4 104.3  22.9* 79.9  20.3
LVESVI at day 1 (ml/m2) 38.7  14.3 59.6  17.8* 32.2  17.8
LVESVI at day 28 (ml/m2) 34.1  12.6 69.4  20.6* 34.1  11.2
Congestive heart failure 2 (3%) 7 (50%)* 1 (9%)
VT or VF 5 (7%) 5 (38%)* 0
Pericardial effusion 0 1 (7%) 0
Extension/recurrent MI 0 0 0
*p  0.05 vs. other groups. Data are expressed as the mean value  SD or number (%) of patients.
LVEDVI  left ventricular end-diastolic volume index; LVESVI  left ventricular end-systolic volume index; LVEF  left
ventricular ejection fraction; MI  myocardial infarction; RWM  regional wall motion; SD  standard deviation; VF 
ventricular fibrillation; VT  ventricular tachycardia; other abbreviations as in Table 1.
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patients with SFR(), in particular, showed poor outcomes.
Slow forward flow seen in the SFR(-) group is associated
with the highest systolic to diastolic velocity ratio, implying
an increase in arterial resistance, possibly associated with an
increased thrombus burden.
Thrombus burden as a cause of TIMI-2 flow. A potential
problem in the treatment of AMI is a possibility of distal
embolization, which may be even more important during
catheter-based treatment (11–13). The consequences of
coronary embolism depend on the size (and number) of
emboli. The smaller the embolus, the greater the chance
that it will migrate distally to a small artery and the less
likelihood of myocardial necrosis. For particle sizes ranging
from 15 to 45 m, baseline blood flow into the embolized
area may actually increase secondary to reactive hyperemia
in the myocardium surrounding the embolized regions (23).
Conversely, the larger the embolic particle, the greater the
chance that it will lodge proximally in a large coronary artery
and result in ischemic myocardial necrosis. Coronary arterial
resistance increases if massive embolization of the coronary
arterial bed occurs. Recently, Gregorini et al. (24) reported
that coronary intervention might also cause neurohormonal
reflexes and vasoconstriction, thus provoking a reduction in
CBFV in patients with AMI. If coronary resistance could
play an important role, it is likely that an increase in
coronary resistance might even abate over time and, there-
fore, might possibly manifest as a transient phenomenon.
An increase in coronary arterial resistance lowers CBFV
throughout the cardiac cycle, with relative augmentation of
systolic flow velocity in patients with SFR(-). The ratio of
systolic to diastolic APV in this group was the highest
among the three subgroups studied. In contrast, the fre-
quency of the no-reflow phenomenon is much lower in the
SFR(-) group than in the SFR() group, implying the
relatively preserved capillary function in the former. Because
of preservation of capillary perfusion, the functional out-
come was better in the SFR(-) group than in the SFR()
group, perhaps because of ultimate dissolution of the mi-
crothrombi.
The CBFV pattern of the right coronary artery is differ-
ent from that of the left coronary artery and is characterized
by the relative dominance of systolic flow. We compared
CBFV variables among the patients with an inferior AMI.
The SFR(-) group was quite different from the TIMI-3
group. Also, ICT was more frequently observed in the right
coronary artery (19 [29%] vs. 19 [49%], p  0.07), and
SFR(-) was most commonly seen in the right coronary
artery. However, multivariate analysis did not determine the
type of infarct-related artery (right or left) as an indepen-
dent predictor of SFR(-).
Capillary damage as a cause of TIMI-2 flow. Gibsons et
al. (25) indicated that SFR was a powerful multivariate
predictor of slow flow, along with residual stenosis and
anterior AMI. It is well known that SFR is a sensitive and
specific finding (91% and 97%, respectively) of the no-
reflow phenomenon (5), and that it is a result of increased
capillary resistance. The increase in capillary resistance in
the area of the no-reflow phenomenon is explained by
interstitial and myocardial cell edema, endothelial blistering,
and/or microvascular spasm and plugging of capillaries by
erythrocytes or leukocytes. In patients with the no-reflow
phenomenon, myocardial blood is not smoothly squeezed
into the venous circulation in systole because of the diffuse
obstruction of capillaries; thus, it may be pushed back to the
coronary artery to produce SFR.
A rapid deceleration of diastolic CBFV is another char-
acteristic of capillary damage. The intramyocardial blood
volume decreases with damage to the capillaries and/or
postcapillary venules. If the coronary inflow exceeds the
capacitance, an impeding effect occurs on the diastolic
coronary inflow by altering perivascular strains, resulting in
a rapid decrease in CBFV. This finding is also supported by
recent findings that a shorter diastolic deceleration time is
associated with poorer tissue perfusion and worse functional
outcomes (7). Indeed, SFR() showed the shortest diastolic
deceleration time among the three subgroups. Because 58%
of the TIMI-2 group had SFR(), the capillary (and
postcapillary venule) damage should still be a main cause of
TIMI-2 flow.
Study limitations. Several potential limitations need to be
addressed. First, our findings are derived from a selected
population of patients with AMI who were successfully
treated with primary PCI. Patients in shock and those with
hemodynamic instability or recurrent AMI were excluded
from the study, because CBFV data were difficult to obtain.
Coronary stenosis was assessed by quantitative angiography.
Intracoronary thrombus on the culprit lesion makes it more
difficult to correctly estimate the degree of stenosis. We used
intravascular ultrasound to rule out the presence of residual
stenosis, when required.
We documented that slow flow is associated with ICT,
but we cannot conclude that a thrombus burden is the sole
cause of TIMI-2 flow in these cases. However, we can state
that an increase in coronary arterial resistance can be a cause
of TIMI-2 flow in the SFR(-) group, as there was no
difference in aortic and right arterial pressures between the
SFR(-) and TIMI-3 groups.
Clinical implications. A differentiation between these two
types of TIMI-2 flow using Doppler flow velocity measure-
ments may facilitate decisions regarding additional inter-
ventions in patients with AMI after successful PCI. Myo-
cardial contrast echocardiography provides the ultimate
information on the grade and spatial extent of capillary
obstruction in the individual patient. Use of improved
antiplatelet therapy and, ultimately, the application of em-
boli entrapment devices in cases of TIMI-2 flow without
SFR may be considered. In contrast, extensive capillary
damage in the area of myocardial necrosis is a main cause of
TIMI-2 flow in cases of SFR(). In these patients, anti-
platelet therapy and/or emboli entrapment devices may be
of little value.
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